Stephanie A. Irving
Kaiser Permanente Center for Health Research(US)
Publications by Year
Research Areas
Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, COVID-19 Impact on Reproduction
Most-Cited Works
- → Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings(2021)498 cited
- → Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022(2022)468 cited
- → Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022(2022)428 cited
- → Risk of anaphylaxis after vaccination in children and adults(2015)379 cited
- → Risk of Intussusception after Monovalent Rotavirus Vaccination(2014)221 cited
- → COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021(2021)201 cited
- → Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021(2022)199 cited
- → Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study(2022)194 cited
- → Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022(2022)192 cited
- → Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021(2021)189 cited